Skip to main content

核準 預測與賠率

·
Trump approval rating on July 3?

Trump approval rating on July 3?

38%

39.0–39.4

$350 交易量

$2.0K Liq.

Ends 6 天內

Trump approval Up or Down this week?

Trump approval Up or Down this week?

57%

Up

$10 交易量

$386 Liq.

Ends 6 天內

Trump approval Up or Down this week?

Trump approval Up or Down this week?

100%

Up

$15.9K 交易量

$0 Liq.

Ends 23 天前

FDA approves Viridian Therapeutics' Veligrotug?

FDA approves Viridian Therapeutics' Veligrotug?

95%

$8.8K 交易量

$4.5K Liq.

Ends 1 天內

FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

11%

$573K 交易量

$6.6K Liq.

3

Ends 6 個月內

Trump Media x TAE Technologies merger closed by June 30?

Trump Media x TAE Technologies merger closed by June 30?

2%

$3.3K 交易量

$6.6K Liq.

Ends 1 天內

FDA approves Unicycive's Oxylanthanum carbonate?

FDA approves Unicycive's Oxylanthanum carbonate?

54%

$5.2K 交易量

$887 Liq.

Ends 大約 14 小時內

FDA approves Arcalyst technology transfer?

FDA approves Arcalyst technology transfer?

42%

$4.5K 交易量

$225 Liq.

Ends 9 天前

U.S. issues passport with Trump's face on it by July 31?

U.S. issues passport with Trump's face on it by July 31?

89%

$12.8K 交易量

$5.9K Liq.

Ends 大約 1 個月內

FDA approves Arcutis' Zoryve cream?

FDA approves Arcutis' Zoryve cream?

84%

$4.5K 交易量

$1.5K Liq.

Ends 大約 14 小時內

FDA approves Daraxonrasib this year?

FDA approves Daraxonrasib this year?

75%

$310 交易量

$1.6K Liq.

Ends 6 個月內

Will McCormick merge with Unilever Foods by...?

Will McCormick merge with Unilever Foods by...?

78%

December 31, 2027

$578 交易量

$2.1K Liq.

Ends 超過 1 年內

US grants license for new nuclear reactor in 2026?

US grants license for new nuclear reactor in 2026?

26%

$24.1K 交易量

$1.5K Liq.

2

Ends 6 個月內

Frequently Asked Questions

Polymarket is the world’s largest prediction market, where you can stay informed and profit from your knowledge by trading on things related to breaking news, politics, sports, elections, crypto, finance, tech, culture, including topics like 核準.

Polymarket currently hosts 13 active markets for 核準 that lets you track or trade on predictions like “Trump approval rating on July 3?”. Whether you are tracking widely debated events or niche outcomes, the platform aggregates real-time odds based on over $653K in trading volume, providing a comprehensive view of fan and investor sentiment.

Each polymarket is a yes/no question, like “US grants license for new nuclear reactor in 2026?”. You buy shares in “yes” or “no” outcomes. Prices reflect crowd-sourced odds and probabilities. For example, if yes is at 30 cents, that’s a 30% chance. Markets resolve based on official results. For multi-outcome events, like “Will McCormick merge with Unilever Foods by...?,” you simply trade on the specific outcome you think will win.

As of today, the most active market is “FDA approves Retatrutide this year?,” where the crowd is currently assigning a 89% chance to No. These odds update in real-time as new information emerges and users trade, offering a dynamic snapshot of what the market believes will happen compared to traditional bookmaker odds.

It cuts through the noise. Unlike polls or punditry, Polymarket shows you real-time odds on 核準 predictions backed by financial conviction that are often faster and more accurate than experts or surveys. You get an unbiased view of what thousands of traders think will actually happen, often more accurate than polls. Plus, you can trade shares and potentially profit if your predictions are spot on.